Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial
Oxyntomodulin has recently been found to decrease body-weight in obese humans and may be a potential anti-obesity therapy.
-
Article
Ghrelin increases food intake in obese as well as lean subjects
To investigate whether effects on food intake are seen in obese subjects receiving exogenous administration of ghrelin.